Constitutive Activation of STATs Upon In Vivo Human Immunodeficiency Virus Infection
Open Access
- 15 December 1999
- journal article
- Published by American Society of Hematology in Blood
- Vol. 94 (12) , 4202-4209
Abstract
Infection by the human immunodeficiency virus (HIV) either upregulates or downregulates the expression of several cytokines and interferons (IFNs) that use the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway for signal transduction. However, very little is known on the state of activation of the JAK/STAT pathway after HIV infection either in vivo or in vitro. In this regard, we report here that a constitutive activation of a C-terminal truncated STAT5 (STAT5▵) and of STAT1 occurs in the majority (∼75%) of individuals with progressive HIV disease. We have further demonstrated that, among peripheral blood mononuclear cells (PBMCs), STAT5▵ is activated preferentially in CD4+ T cells. In contrast to a published report, expression of STATs from PBMCs of infected individuals was comparable with that of seronegative donors. In addition, in vitro infection of mitogen-activated PBMCs with a panel of laboratory-adapted and primary HIV strains characterized by differential usage of chemokine coreceptors did not affect STAT protein levels. However, enhanced activation of STAT was observed after in vitro infection of resting PBMCs and nonadherent PBMCs by different viral strains. Thus, constitutive STAT activation in CD4+T lymphocytes represents a novel finding of interest also as a potential new marker of immunological reconstitution of HIV-infected individuals.Keywords
This publication has 39 references indexed in Scilit:
- JAKS AND STATS: Biological ImplicationsAnnual Review of Immunology, 1998
- Dynamics of fine T-cell subsets during HIV disease and after thymic ablation by mediastinal irradiationSeminars in Immunology, 1997
- STATs and Gene RegulationScience, 1997
- CELLULAR RESPONSES TO INTERFERON-γAnnual Review of Immunology, 1997
- A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells.Journal of Experimental Medicine, 1994
- The IL-2/IL-2 receptor system: A current overviewCell, 1993
- Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes.Journal of Clinical Investigation, 1990
- The Reservoir for HIV-1 in Human Peripheral Blood Is a T Cell That Maintains Expression of CD4Science, 1989
- Qualitative Analysis of Immune Function in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985
- Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.Journal of Clinical Investigation, 1983